Pediatric Neurology
Volume 42, Issue 2 , Pages 77-85 , February 2010

Postural Orthostatic Tachycardia Syndrome: A Clinical Review

  • Jonathan N. Johnson, MD

      Affiliations

    • Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationCommunications should be addressed to: Dr. Johnson; Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine; Mayo Clinic; Gonda 6 South; 200 First Street Southwest; Rochester, MN 55905.
  • ,
  • Kenneth J. Mack, MD, PhD

      Affiliations

    • Division of Child Neurology, Department of Neurology and Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Nancy L. Kuntz, MD

      Affiliations

    • Division of Child Neurology, Department of Neurology and Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Chad K. Brands, MD

      Affiliations

    • Division of General Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Coburn J. Porter, MD

      Affiliations

    • Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  • ,
  • Philip R. Fischer, MD

      Affiliations

    • Division of General Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota

Received 29 January 2009 ,Accepted 6 July 2009.

References 

  1. DaCosta JM. On irritable heart: A clinical study of a form of functional cardiac disorder and its consequences. Am J Med Sci. 1871;61:17
  2. Medow MS, Stewart JM. The postural tachycardia syndrome. Cardiol Rev. 2007;15:67–75
  3. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia?. Neurology. 1993;43:132–137
  4. Stewart JM, Gewitz MH, Weldon A, Munoz J. Patterns of orthostatic intolerance: The orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr. 1999;135:218–225
  5. Stewart JM. Chronic orthostatic intolerance and the postural tachycardia syndrome (POTS). J Pediatr. 2004;145:725–730
  6. Marsh AM, Fischer PR, Brands CK, et al. Dizziness in a pediatric and adolescent referral population. Presented at the Pediatric Academic Societies Annual Meeting, Washington, DC, 2005. Pediatric Academic Societies 2005;57:204.
  7. Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117:2814–2817
  8. Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med. 2003;115:33–40
  9. Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr. 1999;135:494–499
  10. Kanjwal MY, Kosinski DJ, Grubb BP. Treatment of postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia. Curr Cardiol Rep. 2003;5:402–406
  11. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: Clinical features and follow-up study. Mayo Clin Proc. 1999;74:1106–1110
  12. Fischer PR, Brands CK, Porter CJ, et al. High prevalence of orthostatic intolerance in adolescents in a general pediatric referral clinic. Clin Autonom Res. 2005;15:340
  13. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: The Mayo Clinic experience. Mayo Clin Proc. 2007;82:308–313
  14. Rimes KA, Goodman R, Hotopf M, Wessely S, Meltzer H, Chalder T. Incidence, prognosis, and risk factors for fatigue and chronic fatigue syndrome in adolescents: A prospective community study. Pediatrics. 2007;119:e603–e609
  15. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system?. Am J Med. 1997;102:357–364
  16. Wyller VB, Godang K, Morkrid L, Saul JP, Thaulow E, Walloe L. Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: Relation to clinical symptoms. Pediatrics. 2007;120:e129–e137
  17. Skinner J, Driscoll SW, Fischer PR, et al. Normal reference ranges for orthostatic changes in heart rate and blood pressure response in adolescents. Clin Autonom Res. 2007;17:307–308
  18. Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R. Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol. 2002;282:H66–H71
  19. El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart. 1996;75:134–140
  20. Masuki S, Eisenach JH, Schrage WG, et al. Reduced stroke volume during exercise in postural tachycardia syndrome. J Appl Physiol. 2007;103:1128–1135
  21. Burkhardt BE, Pianosi PT, Brands CK, Porter CJ, Weaver AL, Fischer PR. Heart rate response to exercise in adolescents with autonomic dysfunction. Clin Autonom Res. 2007;17:266
  22. Hoeldtke RD, Davis KM. The orthostatic tachycardia syndrome: Evaluation of autonomic function and treatment with octreotide and ergot alkaloids. J Clin Endocrinol Metab. 1991;73:132–139
  23. Antiel RM, Risma JM, Grothe RM, Brands CK, Fischer PR. Orthostatic intolerance and gastrointestinal motility in adolescents with nausea and abdominal pain. J Pediatr Gastroenterol Nutr. 2008;46:285–288
  24. Verdon F, Burnand B, Stubi CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. Br Med J [Clin Res]. 2003;326:1124
  25. Jarjour IT, Jarjour LK. Low iron storage in children and adolescents with neurally mediated syncope. J Pediatr. 2008;153:40–44
  26. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78:1463–1470
  27. Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med. 2000;342:541–549
  28. Nelesen R, Krohn P, Dimsdale JE. Hot-flash hypotension. N Engl J Med. 2004;351:1577–1579
  29. Cameron B, Bharadwaj M, Burrows J, et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis. 2006;193:664–671
  30. Kerr JR. Enterovirus infection of the stomach in chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2008;61:1–2
  31. Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61:43–48
  32. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. Br Med J [Clin Res]. 2006;333:575
  33. Unsworth N, Graves S, Nguyen C, Kemp G, Graham J, Stenos J. Markers of exposure to spotted fever rickettsiae in patients with chronic illness, including fatigue, in two Australian populations. Q J Med. 2008;101:269–274
  34. Chapenko S, Krumina A, Kozireva S, et al. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol. 2006;37(Suppl. 1):S47–S51
  35. Kerr JR, Mattey DL. Preexisting psychological stress predicts acute and chronic fatigue and arthritis following symptomatic parvovirus B19 infection. Clin Infect Dis. 2008;46:e83–e87
  36. Marques A. Chronic Lyme disease: A review. Infect Dis Clin North Am. 2008;22:341–360
  37. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA. Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol. 2008;197:63–69
  38. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–855
  39. Ishitobi M, Haginoya K, Kitamura T, Munakata M, Yokoyama H, Iinuma K. Acute dysautonomia: Complete recovery after two courses of IVIG. Brain Dev. 2004;26:542–544
  40. Grubb BP, Karabin B. Cardiology patient page. Postural tachycardia syndrome: Perspectives for patients. Circulation. 2008;118:e61–e62
  41. Lai CC, Fischer PR, Brands CK, et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and β-blockers. Pac Clin Electrophysiol. 2009;32:234–238
  42. Wyller VB, Thaulow E, Amlie JP. Treatment of chronic fatigue and orthostatic intolerance with propranolol. J Pediatr. 2007;150:654–655
  43. Vaziri ND. Cardiovascular effects of erythropoietin and anemia correction. Curr Opin Nephrol Hypertens. 2001;10:633–637
  44. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med. 1993;329:611–615
  45. Vernino S, Sandroni P, Singer W, Low PA. Invited article: Autonomic ganglia: Target and novel therapeutic tool. Neurology. 2008;70:1926–1932
  46. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: An exploratory study. J Am Acad Child Adolesc Psychiatry. 2004;43:1234–1242
  47. Robertson D, Goldberg MR, Onrot J, et al. Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N Engl J Med. 1986;314:1494–1497
  48. Locke GR, Ackerman MJ, Zinsmeister AR, Thapa P, Farrugia G. Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: Evidence of an intestinal channelopathy. Am J Gastroenterol. 2006;101:1299–1304
  49. Moss AJ, Kass RS. Long QT syndrome: From channels to cardiac arrhythmias. J Clin Invest. 2005;115:2018–2024
  50. Hindocha N, Nashef L, Elmslie F, et al. Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. Epilepsia. 2008;49:360–365

PII: S0887-8994(09)00345-2

doi: 10.1016/j.pediatrneurol.2009.07.002

Pediatric Neurology
Volume 42, Issue 2 , Pages 77-85 , February 2010